Benefits
Bone mineral density
In a 7-year follow-up of 172 women who had already bought the product for 1 to 7 years, bone mineral density rose about 1.04% a year, against an expected decline of about 0.4% a year from reference databases. Two earlier open-label studies of bone plans built around it (6 months and up to 1 year) also reported gains over expected. None had randomization or a placebo group, so the gains cannot be credited to the supplement.
Mineral cofactors for bone
The studied formulas paired the algae calcium with vitamin D3 and vitamin K2, and one 6-month plan added extra magnesium; both plans in that study also included strontium citrate. Because each study tested a whole plan, the contribution of the algae calcium is uncertain: it cannot be separated from these added nutrients or from strontium, which by itself makes bone density scans read higher.
Plant-based and food-form
Made by milling whole harvested algae, it offers an algae-derived alternative to standard calcium salts for people who prefer that source. No published human study has compared its effects with calcium carbonate or citrate; a registered absorption comparison with a calcium carbonate product was completed in 2010 but has no posted results.
Mechanism of action
Bone-forming cells in culture
In a cell study, AlgaeCal raised markers of bone-forming activity (alkaline phosphatase, DNA synthesis) in a cultured human fetal osteoblast cell line more than calcium carbonate or calcium citrate. No human absorption comparison with another calcium source has been published, so better bioavailability is unproven.
Vitamin K2 and D3 cofactors
Low vitamin D status reduces calcium absorption, and vitamin K is a cofactor that activates osteocalcin, a main protein in bone. The AlgaeCal studies did not measure osteocalcin, artery calcium or heart outcomes.
Clinical trials
Open-label, uncontrolled follow-up of customers who had bought AlgaeCal for 1 to 7 years and were offered free repeat scans and blood tests; lead author from Integrative Health Technologies, which ran the earlier company-sponsored AlgaeCal studies. The abstract does not state the funder. Bone density was compared with expected change in 3 reference databases; a separate group of 5,070 people was the comparison for blood chemistry only. (Kaats et al. 2016, J Am Coll Nutr)
172 women with repeat DEXA bone scans and 30 with repeat blood chemistry, all of whom had bought and taken the product for 1 to 7 years.
Bone mineral density rose about 1.04% a year, 7.3% over 7 years, against expected changes of about -0.4% a year in the reference databases. Annual changes in a 45-test blood panel showed no safety signal. With self-selected long-term buyers, no randomization and no placebo group, the change could reflect diet, exercise, other supplements or how the expected-change figure was built.
Open-label, sequential (not randomized) comparison with no placebo group, funded by a nutrition company the paper does not name and in part by Integrative Health Technologies, in which the last author holds equity; an independent statistician ran the analyses. Both plans included 680 mg/day strontium citrate, vitamin D3, vitamin K2, and activity and education components. (Michalek et al. 2011, Nutr J)
158 adults on AlgaeCal 1 (125 completed), then a second group of 58 on AlgaeCal 2 (51 completed); mostly women, mean age about 55.
Mean annualized bone mineral density change above expected was 1.15% (AlgaeCal 1) and 2.79% (AlgaeCal 2). Change from baseline was not significant for AlgaeCal 1 (0.48%, p = 0.14) but was for AlgaeCal 2 (2.18%). Strontium deposited in bone makes DXA scans read higher, so part of any gain may be a measurement effect. No clinically significant blood chemistry changes were found.
Open-label, sequential study with no placebo group; for budget reasons the study sponsor compared results with an estimated expected loss of 0.75% a year instead of enrolling a control group. Run by Integrative Health Technologies; the full text identifies the supplement (research code DN0361) as AlgaeCal. (Kaats et al. 2011, Int J Med Sci)
176 women over 40 (of 414 tested); one plan gave 750 mg/day algae calcium with 1,000 IU vitamin D3 for one year, the others added more vitamin D3, other nutrients, and activity and education components.
Women with above-average self-reported adherence had greater bone mineral density increases than the two expected-change reference groups, and the most comprehensive plan did best. Results were split by self-reported adherence, with no placebo comparison. Blood chemistry and quality of life did not change significantly.